Back to Newsroom

Cyclacel Reviews 2013 Achievements and Announces Key Business Objectives for 2014

BERKELEY HEIGHTS, N.J., Jan. 13, 2014 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company) today reviewed 2013 achievements and provided an outline of the Company’s key clinical development objectives for 2014, which will be highlighted at the Company’s presentation during the Biotech Showcase™ 2014 Conference at 9:30 a.m. PST, Monday, Jan. 13, 2014, at the Parc 55 Wyndham Hotel – Union Square at 55 Cyril Magnin Street in San Francisco.